Tricaprilin not checked

Cerecin · AC-SD-03 · AC-OL-01

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
6 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Each dose of IMP will be administered orally 30 minutes after completing a full meal. There is 1 g of tricaprilin per 2 ml of AC-OLE-01-VA. Participants will titrate from 5 g twice a day to 20 g twice a day, up to 40 g total daily dose of tricaprilin; 80 ml total daily dose of AC-OLE-01-VA, over the course of 2-4 weeks.”In the company’s words, NCT05809908 on ClinicalTrials.gov
Tested for
Alzheimer Disease
Main trialPhase 3
“The purpose of this study is to evaluate the effects of tricaprilin (20 g twice a day) on cognition, global function, activities of daily living, resource utilisation, safety, and tolerability, in participants with mild to moderate AD dementia. This is a randomised, double-blind, placebo-controlled, parallel-group, multi-centre design in up to 535 participants.”In the company’s words, NCT05809908 on ClinicalTrials.gov
Other names
AC-SD-03 · AC-OL-01 · AC-1204 · AC-1202

Other drugs for Alzheimer Disease

All 90 drugs for Alzheimer Disease

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Jan 2030 Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
Phase 3Withdrawn 31 Dec 2023 A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension
Phase 2/3Completed 24 Oct 2016 AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Phase 2Completed 7 Feb 2022 Tricaprilin Phase 2 Pilot Study in Migraine
Phase 1Terminated 18 Mar 2022 Tricaprilin Liquid Formulation PK Study
Phase 1Completed 4 Dec 2023 Tricaprilin Infantile Spasms Pilot Study
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Tricaprilin

Following is part of Solo: you see every change to Tricaprilin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in